|
[1]
|
Li Q, Guan XH, Wu P, Wang XY, Zhou L, Tong YQ, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 2020;382(13):1199 − 207. http://dx.doi.org/10.1056/NEJMoa2001316CrossRef
|
|
[2]
|
Zou HC, Shu YL, Feng TJ. How Shenzhen, China avoided widespread community transmission: a potential model for successful prevention and control of COVID-19. Infect Dis Poverty 2020;9(1):89. http://dx.doi.org/10.1186/s40249-020-00714-2CrossRef
|
|
[3]
|
Zhang RN, Liang ZR, Pang MF, Yang XP, Wu JW, Fang YS, et al. Mobility trends and effects on the COVID-19 epidemic — Hong Kong, China. China CDC Wkly 2021;3(8):159 − 61. http://dx.doi.org/10.46234/ccdcw2021.020CrossRef
|
|
[4]
|
Snounou G, Singh B. Nested PCR analysis of Plasmodium parasites. In: Doolan DL, editor. Malaria methods and protocols: methods and protocols. Totowa: Humana Press. 2002; p. 189-203. http://dx.doi.org/10.1385/1-59259-271-6:189.http://dx.doi.org/10.1385/1-59259-271-6:189 |
|
[5]
|
Sutherland CJ, Tanomsing N, Nolder D, Oguike M, Jennison C, Pukrittayakamee S, et al. Two nonrecombining sympatric forms of the human malaria parasite Plasmodium ovale occur globally. J Infect Dis 2010;201(10):1544 − 50. http://dx.doi.org/10.1086/652240CrossRef
|
|
[6]
|
Oguike MC, Betson M, Burke M, Nolder D, Stothard JR, Kleinschmidt I, et al. Plasmodium ovale curtisi and Plasmodium ovale wallikeri circulate simultaneously in African communities. Int J Parasitol 2011;41(6):677 − 83. http://dx.doi.org/10.1016/j.ijpara.2011.01.004CrossRef
|
|
[7]
|
Kishore R, Dhakad S, Arif N, Dar L, Mirdha BR, Aggarwal R, et al. COVID-19: possible cause of induction of relapse of Plasmodium vivax infection. Indian J Pediatr 2020;87(9):751 − 2. http://dx.doi.org/10.1007/s12098-020-03441-6CrossRef
|
|
[8]
|
White NJ. Determinants of relapse periodicity in Plasmodium vivax malaria. Malar J 2011;10:297. http://dx.doi.org/10.1186/1475-2875-10-297CrossRef
|
|
[9]
|
Nghochuzie NN, Olwal CO, Udoakang AJ, Amenga-Etego LNK, Amambua-Ngwa A. Pausing the fight against malaria to combat the COVID-19 pandemic in Africa: is the future of malaria bleak? Front Microbiol 2020;11:1476. http://dx.doi.org/10.3389/fmicb.2020.01476CrossRef
|
|
[10]
|
Sardar S, Sharma R, Alyamani TYM, Aboukamar M. COVID-19 and Plasmodium vivax malaria co-infection. IDCases 2020;21:e00879. http://dx.doi.org/10.1016/j.idcr.2020.e00879CrossRef
|
|
[11]
|
Cuadrado-Payán E, Montagud-Marrahi E, Torres-Elorza M, Bodro M, Blasco M, Poch E, et al. SARS-CoV-2 and influenza virus co-infection. Lancet 2020;395(10236):E84. http://dx.doi.org/10.1016/S0140-6736(20)31052-7CrossRef
|